AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Aduro BioTechAMAG PharmaceuticalsLexicon PharmaceuticalsGemphire TherapeuticsStemline Therapeutics
SymbolNASDAQ:ADRONASDAQ:AMAGNASDAQ:LXRXNASDAQ:GEMPNASDAQ:STML
Price Information
Current Price$3.26$8.00$1.91$13.17$11.86
52 Week RangeHoldHoldHoldBuyHold
Beat the Market™ Rank
Overall Score1.61.81.70.51.4
Analysis Score3.23.03.10.02.2
Community Score3.12.22.52.73.2
Dividend Score0.00.00.00.00.0
Ownership Score1.03.01.00.01.0
Earnings & Valuation Score0.60.61.90.00.6
Analyst Ratings
Consensus RecommendationHoldHoldHoldBuyHold
Consensus Price Target$5.50$8.88$4.53N/A$11.31
% Upside from Price Target68.71% upside10.94% upside136.91% upsideN/A-4.62% downside
Trade Information
Market Cap$264.35 million$285.15 million$217.15 million$195.84 million$621.46 million
Beta0.30.981.132.821.34
Average Volume945,356715,426950,623116,3181,391,306
Sales & Book Value
Annual Revenue$17.26 million$327.75 million$322.07 millionN/A$43.22 million
Price / Sales15.270.840.63N/A14.41
CashflowN/AN/A$1.65 per shareN/AN/A
Price / CashN/AN/A1.16N/AN/A
Book Value$0.74 per share$7.70 per share$0.51 per share$0.54 per share$2.81 per share
Price / Book4.411.043.75N/A4.22
Profitability
Net Income$-82,370,000.00$-466,460,000.00$130.13 million$-23,640,000.00$-76,820,000.00
EPS($1.03)($6.88)$1.35N/A($1.83)
Trailing P/E RatioN/AN/A3.080.00N/A
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-243.93%-115.05%26.59%N/A-150.30%
Return on Equity (ROE)-86.31%-28.28%125.61%-419.70%-48.14%
Return on Assets (ROA)-21.67%-12.24%23.28%-173.05%-41.35%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.52%1.14%4.28%N/AN/A
Current Ratio9.13%1.54%3.63%0.67%7.43%
Quick Ratio9.13%1.37%3.58%0.67%7.37%
Ownership Information
Institutional Ownership Percentage48.14%N/A97.99%17.53%75.80%
Insider Ownership Percentage5.90%4.90%6.40%22.70%11.20%
Miscellaneous
Employees152467202992
Shares Outstanding80.84 million34.27 million106.97 million14.87 million52.51 million
Next Earnings Date8/6/2020 (Estimated)8/5/2020 (Estimated)7/29/2020 (Estimated)N/A5/29/2020 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.